Skip to main content
Log in

CT-based whole lung radiomics nomogram: a tool for identifying the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the value of CT-based whole lung radiomics nomogram for identifying the risk of cardiovascular disease (CVD) in patients with chronic obstructive pulmonary disease (COPD).

Materials and methods

A total of 974 patients with COPD were divided into a training cohort (n = 402), an internal validation cohort (n = 172), and an external validation cohort (n = 400) from three hospitals. Clinical data and CT findings were analyzed. Radiomics features of whole lung were extracted from the non-contrast chest CT images. A radiomics signature was constructed with algorithms. Combined with the radiomics score and independent clinical factors, multivariate logistic regression analysis was used to establish a radiomics nomogram. ROC curve was used to analyze the prediction performance of the model.

Results

Age, weight, and GOLD were the independent clinical factors. A total of 1218 features were extracted and reduced to 15 features to build the radiomics signature. In the training cohort, the combined model (area under the curve [AUC], 0.731) showed better discrimination capability (p < 0.001) than the clinical factors model (AUC, 0.605). In the internal validation cohort, the combined model (AUC, 0.727) performed better (p = 0.032) than the clinical factors model (AUC, 0.629). In the external validation cohort, the combined model (AUC, 0.725) performed better (p < 0.001) than the clinical factors model (AUC, 0.690). Decision curve analysis demonstrated the radiomics nomogram outperformed the clinical factors model.

Conclusion

The CT-based whole lung radiomics nomogram has the potential to identify the risk of CVD in patients with COPD.

Clinical relevance statement

This study helps to identify cardiovascular disease risk in patients with chronic obstructive pulmonary disease on chest CT scans.

Key Points

• To investigate the value of CT-based whole lung radiomics features in identifying the risk of cardiovascular disease in chronic obstructive pulmonary disease patients.

• The radiomics nomogram showed better performance than the clinical factors model to identify the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.

• The radiomics nomogram demonstrated excellent performance in the training, internal validation, and external validation cohort (AUC, 0.731; AUC, 0.727; AUC, 0.725).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data sharing

Data generated or analyzed during the study are available from the corresponding author by request.

Abbreviations

AECOPD:

Acute exacerbation of chronic obstructive pulmonary disease

AUC:

Area under the ROC curve

CI:

Confidence interval

COPD:

Chronic obstructive pulmonary disease

CT:

Computed tomography

CVD:

Cardiovascular disease

DCA:

Decision curve analysis

FEV1%:

Percent predicted of forced expiratory flow in 1 s

FEV1:

Forced expiratory volume in 1 s

ICD:

International Classification of Disease

mRMR:

Maximal redundancy minimal relevance

NPV:

Negative predictive value

PPV:

Positive predictive value

PRISm:

Preserved ratio impaired spirometry

ROC:

Receiver operating characteristic

VRF:

Vascular risk factors

References

  1. David MGH, Gerard JC, Alberto P et al (2022) Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Physiol Lung Cell Mol Physiol 203(1):24–36

    Google Scholar 

  2. Wang C, Xu J, Yang L et al (2018) Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391(10131):1706–1717

    Article  PubMed  Google Scholar 

  3. Christenson SA, Smith BM, Bafadhel M et al (2022) Chronic obstructive pulmonary disease. Lancet 399(10342):2227–2242

    Article  PubMed  Google Scholar 

  4. Negewo NA, Gibson PG, McDonald VM (2015) COPD and its comorbidities: impact, measurement and mechanisms. Respirology 20(8):1160–1171

    Article  PubMed  Google Scholar 

  5. Zhao D, Liu J, Wang M et al (2019) Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 16(4):203–212

    Article  PubMed  Google Scholar 

  6. Chen W, Thomas J, Sadatsafavi M et al (2015) Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 3(8):631–639

    Article  PubMed  Google Scholar 

  7. Austin V, Crack PJ, Bozinovski S et al (2016) COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond) 130(13):1039–1050

    Article  PubMed  Google Scholar 

  8. Rabe KF, Hurst JR, Suissa S (2018) Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev 27(149):180057

  9. Morgan AD, Zakeri R, Quint JK (2018) Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis 12:1753465817750524

    Article  PubMed  PubMed Central  Google Scholar 

  10. Du Y, Li Q, Sidorenkov G et al (2021) Computed tomography screening for early lung cancer, COPD and cardiovascular disease in Shanghai: rationale and design of a population-based comparative study. Acad Radiol 28(1):36–45

    Article  PubMed  Google Scholar 

  11. Kockelkoren R, Jairam PM, Murchison JT et al (2018) Validation of an imaging based cardiovascular risk score in a Scottish population. Eur J Radiol 98:143–149

    Article  PubMed  Google Scholar 

  12. Balbirsingh V, Mohammed AS, Turner AM et al (2022) Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review. Thorax Thoraxjnl 30:thoraxjnl-2021-218333

  13. Cury RC, Leipsic J, Abbara S et al (2022) CAD-RADS™ 2.0 – 2022 coronary artery disease – reporting and data system an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 16(6):536–557

  14. Sergio HRRS, Amil MS (2021) Lung function and cardiovascular disease: a link. Trends Cardiovasc Med 31(2):93–98

    Article  Google Scholar 

  15. Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762

    Article  PubMed  Google Scholar 

  16. Mayerhoefer ME, Materka A, Langs G et al (2020) Introduction to radiomics. J Nucl Med 61(4):488–495

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ather S, Kadir T, Gleeson F (2020) Artificial intelligence and radiomics in pulmonary nodule management: current status and future applications. Clin Radiol 75(1):13–19

    Article  CAS  PubMed  Google Scholar 

  18. Qiu Y, Wang Y, Shen N (2022) Nomograms for predicting coexisting cardiovascular disease and prognosis in chronic obstructive pulmonary disease_ a study based on NHANES data. Can Respir J 2022:5618376

  19. Chen QA-O, Pan T, Wang YN et al (2023) A coronary CT angiography radiomics model to identify vulnerable plaque and predict cardiovascular events. Radiology 307(2):e221693

    Article  PubMed  Google Scholar 

  20. Coats V (2018) DESPRéS J P, ALMéRAS N, et al Ectopic adiposity and cardiometabolic health in COPD. Int J Chron Obstruct Pulmon Dis 15(13):3331–3340

    Article  Google Scholar 

  21. Labaki WW, Rosenberg SR (2020) Chronic obstructive pulmonary disease. Ann Intern Med 173(3):ITC17–ITC32

    Article  PubMed  Google Scholar 

  22. Halpin DA-O, Criner GJ, Papi A et al (2021) Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 203(1):24–36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gomes AF, Brasil DM, Silva AIV et al (2020) Accuracy of ITK-SNAP software for 3D analysis of a non-regular topography structure. Oral Radiol 36(2):183–189

    Article  PubMed  Google Scholar 

  24. Wan ES, Balte P, Schwartz JE et al (2021) Association between preserved ratio impaired spirometry and clinical outcomes in US adults. JAMA 326(22):2287–2298

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zheng J, Zhou R, Zhang Y et al (2023) Preserved ratio impaired spirometry in relationship to cardiovascular outcomes: a large prospective cohort study. Chest 163(3):610–623

    Article  PubMed  Google Scholar 

  26. WHITTAKER HR, BLOOM C, MORGAN A, et al (2021) Accelerated FEV1decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients. Eur Respir J 4;57(3):2000918

  27. Kunisaki KA-O, Dransfield MT, Anderson JA et al (2018) Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med 198(1):51–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Løkke AA-O, Hilberg OA-O, Lange PA-O et al (2023) Exacerbations predict severe cardiovascular events in patients with COPD and stable cardiovascular disease-a nationwide, population-based cohort study. Int J Chron Obstruct Pulmon Dis 18:419–429

    Article  PubMed  PubMed Central  Google Scholar 

  29. Yakar HI, Kanbay A (2020) Could monocyte level/HDL cholesterol ratio predict cardiovascular diseases in patients with COPD? Niger J Clin Pract 23(4):450–455

    Article  CAS  PubMed  Google Scholar 

  30. Li J, Wang Q, Zhang Q et al (2020) Higher blood vascular cell adhesion molecule-1 is related to the increased risk of cardiovascular events in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 15:2289–2295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rizzo S, Botta F, Raimondi S et al (2018) Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2(1):36

    Article  PubMed  PubMed Central  Google Scholar 

  32. Huang W, Deng H, Li Z et al (2023) Baseline whole-lung CT features deriving from deep learning and radiomics: prediction of benign and malignant pulmonary ground-glass nodules. Front Oncol 13:1255007

    Article  PubMed  PubMed Central  Google Scholar 

  33. Zhou T, Tu W, Dong P et al (2023) CT-based radiomic nomogram for the prediction of chronic obstructive pulmonary disease in patients with lung cancer. Acad Radiol S1076–6332(23):00139–00143

    Google Scholar 

  34. Pujadas ER, Raisi-Estabragh Z, Szabo L et al (2023) Prediction of incident cardiovascular events using machine learning and CMR radiomics. Eur Radiol 33(5):3488–3500

    Article  PubMed  Google Scholar 

  35. Yang M, Cao Q, Xu Z et al (2022) Development and validation of a machine learning-based radiomics model on cardiac computed tomography of epicardial adipose tissue in predicting characteristics and recurrence of atrial fibrillation. Front Cardiovasc Med 9:813085

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received funding by the National Key R&D Program of China (2022YFC2010002, 2022YFC2010000); the National Natural Science Foundation of China (82171926, 81930049, 81871321); the Medical Imaging Database Construction Program of National Health Commission (YXFSC2022JJSJ002); the Clinical Innovative Project of Shanghai Changzheng Hospital (2020YLCYJ-Y24); and the program of Science and Technology Commission of Shanghai Municipality (21DZ2202600).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Fan.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Li Fan.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors (TaoHu Zhou) has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained (2022SL068).

Study subjects or cohorts overlap

No study subjects or cohorts have been previously reported.

Methodology

• retrospective

• observational

• multicenter study

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

XiaoQing Lin and TaoHu Zhou contributed equally to this work.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, X., Zhou, T., Ni, J. et al. CT-based whole lung radiomics nomogram: a tool for identifying the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease. Eur Radiol (2024). https://doi.org/10.1007/s00330-023-10502-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00330-023-10502-9

Keywords

Navigation